Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
7.06
+0.05 (0.71%)
At close: Sep 18, 2026, 4:00 PM EDT
6.86
-0.20 (-2.83%)
After-hours: Sep 18, 2026, 7:18 PM EDT
Quoin Pharmaceuticals Market Cap
Quoin Pharmaceuticals has a market cap or net worth of $33.92 million as of September 18, 2026. Its market cap has increased by 571.32% in one year.
Market Cap
33.92M
Enterprise Value
25.14M
1-Year Change
571.32%
Ranking
Category
Stock Price
$7.06
ChartMarket Cap Chart
Since October 29, 2021, Quoin Pharmaceuticals's market cap has decreased from $97.17M to $33.92M, a decrease of -65.09%. That is a compound annual growth rate of -19.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 33.92M | 180.16% |
| Dec 31, 2025 | 12.11M | 127.24% |
| Dec 31, 2024 | 5.33M | 10.02% |
| Dec 29, 2023 | 4.84M | -29.65% |
| Dec 30, 2022 | 6.88M | -54.69% |
| Dec 31, 2021 | 15.19M | -84.36% |
| Oct 29, 2021 | 97.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Actinium Pharmaceuticals | 38.36M |
| Celularity | 37.92M |
| CervoMed | 36.74M |
| BriaCell Therapeutics | 36.70M |
| aTyr Pharma | 35.61M |
| Filana Therapeutics | 35.07M |
| Context Therapeutics | 33.82M |
| Aligos Therapeutics | 32.72M |